Source: BioPortfolio

KHB: Shanghai Kehua Bioengineering Co Ltd 002022 Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 25042018 Prices from USD $250

SummaryShanghai Kehua Bioengineering Co Ltd KHB is a medical device company that develops manufactures and markets in vitro diagnostic devices and related products. The company's product portfolio includes enzyme immunoassay kits clinical chemistry reagent...

Read full article »
Annual Revenue
$500M-1.0B
Employees
1.0-5.0K
CEO Avatar

General Manager

Xiaodong Jin

CEO Approval Rating

64/100

Read more